No. 182, Beijing Road
Eco & Tech Dev Zn
Chengdu 610100
China
86 28 8484 6555
https://www.kangh.com
Sector(s): Healthcare
Industry: Biotechnology
Full-time employees: 672
Name | Title | Pay | Exercised | Year born |
---|---|---|---|---|
Mr. Zhen Tao Wang | Chairman & GM | N/A | N/A | 1965 |
Mr. Wennian Wu | Deputy GM & CFO | N/A | N/A | 1983 |
Mr. Wenli Hou | Deputy GM & Director | N/A | N/A | 1984 |
Mr. Hao Lu | Deputy GM & Secretary of the Board | N/A | N/A | 1986 |
Mr. Huaigong Chen | Deputy GM & Quality Manager | N/A | N/A | 1973 |
Mr. Wanfeng Sun | Deputy General Manager | N/A | N/A | 1980 |
Chengdu Kanghua Biological Products Co., Ltd. engages in the research, development, production, sale, and technical service of biological products in China. It offers group ACYW135 meningococcal polysaccharide vaccines; and freeze-dried human diploid cell rabies vaccines. The company also develops seasonal influenza vaccines without preservatives, which completed phase III clinical trials. In addition, it exports its products. The company was founded in 2004 and is based in Chengdu, China.
Chengdu Kanghua Biological Products Co., Ltd.’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.